Skip to main content
. 2019 Nov 8;217(2):e20191009. doi: 10.1084/jem.20191009

Figure 7.

Figure 7.

A schematic diagram showing direct or T cell–dependent killing of CML cells by imatinib for achieving CMR. Teff, effector T cell.